文献速递神经技术与安全MR

钆基对比剂对衰老大鼠脑磁共振成像信号强度与弛豫时间纵向变化的影响

The Effect of Gadolinium-Based Contrast Agents on Longitudinal Changes of Magnetic Resonance Imaging Signal Intensities and Relaxation Times in the Aging Rat Brain.
PubMed 文献 · Invest Radiol · 2022-02-04

研究将25只Wistar-Han大鼠分为5组,分别给予生理盐水、钆布醇或钆双胺,在1年内纵向评估小脑深部核团与苍白球的MRI信号强度及弛豫时间变化;广泛MRI评估未显示钆布醇多次暴露相关信号或弛豫时间改变,而所有组均观察到与年龄相关的T1、T2缩短及信号比变化,可能干扰将MRI作为脑内钆沉积指标的判断。

要点

  • 钆布醇多次暴露未显示小脑深部核团和苍白球信号强度或弛豫时间相关改变
  • 所有组均见年龄相关T1、T2缩短及小脑深部核团/脑桥T2信号比升高、苍白球/梨状皮层T2信号比降低
  • 这些年龄相关变化可能干扰将MRI作为脑内钆沉积指标的判断

核心结论

  • 广泛MRI评估未显示钆布醇多次暴露与小脑深部核团和苍白球信号强度或弛豫时间改变相关的迹象;所有组均观察到年龄相关的苍白球T1和T2缩短、小脑深部核团/脑桥T2信号比升高及苍白球/梨状皮层T2信号比降低,此类年龄相关变化可能干扰将MRI作为脑内钆存在指标的判断。

研究设计与样本

  • 动物实验:25只Wistar-Han大鼠等分为5组,分别给予生理盐水(I-III组)、1.8 mmol Gd/kg体重的钆布醇(IV组)或钆双胺(V组),首次给药为连续4天每周8次注射;在末次给药后1周(所有组)、5、12、20、26周(生理盐水II组、钆布醇组、钆双胺组)及35、44、52周(生理盐水III组、钆布醇组、钆双胺组)行T1WI、T2WI及弛豫图扫描;生理盐水I组于1周后处死,生理盐水II组于26周后处死,其余组于52周后处死;以电感耦合等离子体质谱及激光烧蚀-电感耦合等离子体质谱成像定量脑组织钆、铁、锰含量。

关键影像表现/征象

  • T1WI信号强度比在各区域均未显示随年龄的显著趋势。
  • 52周时组间分析显示钆双胺与其对照比较者在DCN/P及GP/PC区域比值上存在显著差异。
  • T1弛豫时间随年龄增长在GP下降,所有组首次与末次测量差异为10%至20%;DCN下降小于10%,仅钆双胺组显著下降(DCN:P=0.0158)。
  • 末次测量时点组间差异:DCN中钆双胺与生理盐水III组T1值差异有统计学意义(P=0.0153),GP中钆双胺与钆布醇组差异有统计学意义(P=0.0287)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of the study was to investigate the possible influence of changes in the brain caused by age on relaxometric and relaxation time-weighted magnetic resonance imaging (MRI) parameters in the deep cerebellar nuclei (DCN) and the globus pallidus (GP) of Gd-exposed and control rats over the course of 1 year.

MATERIALS AND METHODS: Twenty-five Wistar-Han rats were equally subdivided into 5 groups and initially received 8 injections on 4 consecutive days per week of either 3.6 mL/kg body weight saline (group I-III) or 1.8 mmol Gd/kg body weight gadobutrol (group IV) or gadodiamide (group V). T1- and T2-weighted scans, as well as relaxation maps, were acquired at 1 week (all groups); 5, 12, 20, and 26 weeks (saline II, gadobutrol, gadodiamide); and at 35, 44, and 52 weeks (saline III, gadobutrol, gadodiamide) after the last administration. Saline I was euthanized after 1 week, saline II after 26 weeks, and the remaining groups after 52 weeks. Signal intensities (SIs) were evaluated for the DCN/pons (P) and the GP/piriform cortex (PC) ratios, and relaxation times for the DCN and the GP. Brain tissue was extracted, and the gadolinium, iron, and manganese contents were quantified with inductively coupled plasma mass spectrometry (ICP-MS) and laser ablation-ICP-MS imaging.

RESULTS: T1-weighted SI ratios did not show any significant trend with age in any region. The between-group analysis at 52 weeks resulted in a significant difference for the DCN/P and GP/PC region ratio between gadodiamide and its comparators. T1 relaxation times dropped with increasing age in the GP with a 10% to 20% difference between first and last measurement for all groups, and in the DCN <10% with a significant decrease for the gadodiamide group only (DCN: P = 0.0158). Group-related differences were observed at the last measurement time point for T1 values between gadodiamide and saline III in the DCN (P = 0.0153) and gadodiamide and gadobutrol in the GP (P = 0.0287). Analysis of the SI ratios of the T2-weighted images revealed a significant increase for the DCN/P and a decrease for the GP/PC with increasing age for all groups and no differences at 52 weeks after the last injection between groups. T2 values of the GP showed a significant linear decrease over time for all groups (saline I-III: P = 0.0101; gadobutrol: P = 0.0001; gadodiamide: P = 0.0142) in the aging rat brain. Quantitative imaging of manganese and iron by laser ablation-ICP-MS showed a linear increase for the saline groups in the GP for both metals (Fe: P < 0.0001; Mn: P = 0.0306) and in the DCN for manganese only (P = 0.0187), but no differences between groups at 52 weeks.

CONCLUSIONS: Extensive MRI evaluation did not reveal an indication of SI or relaxation time changes associated with multiple exposure to the macrocyclic-chelated GBCA gadobutrol in the DCN and the GP. With increasing age, a T1 and T2 shortening in the GP and an increase in T2-weighted SI ratio in the DCN/P, as well as a decrease in the GP/PC, were observed for all groups. Such age-related changes can potentially bias MRI results as an indicator for gadolinium presence in the brain.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Green, Jost, Frenzel, et al. The Effect of Gadolinium-Based Contrast Agents on Longitudinal Changes of Magnetic Resonance Imaging Signal Intensities and Relaxation Times in the Aging Rat Brain. Invest Radiol. 2022. PMID: 35125411. doi:10.1097/RLI.0000000000000857

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。